Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Castle Biosciences Inc (NQ: CSTL )

16.89 -0.50 (-2.88%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 275,532
Open 17.53
Bid (Size) 10.22 (1)
Ask (Size) 18.50 (2)
Prev. Close 17.39
Today's Range 16.80 - 17.58
52wk Range 12.50 - 30.08
Shares Outstanding 25,167,365
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Castle Biosciences, Leading Skin Cancer Expert, Darrell Rigel, M.D., M.S., and IMPACT Melanoma Board Member to Ring Nasdaq Closing Bell on Sept. 27, 2023, to Raise Awareness of Melanoma
From Castle Biosciences, Inc.
Via Business Wire
Castle Biosciences Ranked Third Among 2023 Top Workplaces in the Healthcare Industry
From Castle Biosciences Inc.
Via Business Wire

Performance

YTD
-25.86%
-25.86%
1 Month
-15.25%
-15.25%
3 Month
+24.65%
+24.65%
6 Month
-24.36%
-24.36%
1 Year
-35.24%
-35.24%

More News

Read More
TissueCypher® Barrett’s Esophagus Test Outperformed Standard of Care in Risk-Stratifying Patients with Barrett’s Esophagus
From Castle Biosciences Inc.
Via Business Wire
Why Castle Biosciences Stock Is Jumping Today
Via The Motley Fool
Castle Biosciences Announces Receipt of New York Laboratory Permit for Pittsburgh Laboratory
From Castle Biosciences Inc.
Via Business Wire
Integrating Drug-Drug Interactions and Lifestyle Factors with Drug-Gene Interactions Provided by Castle Biosciences’ IDgenetix® Test Significantly Impacted the Number of Drug Recommendations for Patients with Moderate to Severe Depression
From Castle Biosciences Inc.
Via Business Wire
TissueCypher® Provides Clinically-Impactful Risk Stratification in Patients with Barrett’s Esophagus
From Castle Biosciences Inc
Via Business Wire
Castle Biosciences's Earnings: A Preview
Via Benzinga
Why Shares of Castle Biosciences Fell This Week
Via The Motley Fool
Castle Biosciences to Highlight Clinical Value of IDgenetix® Test at Psych Congress 2023
From Castle Biosciences Inc.
Via Business Wire
Castle Biosciences to Participate in Upcoming Investor Conferences
From Castle Biosciences Inc.
Via Business Wire
New Publication Highlights the Ability of the TissueCypher® Barrett’s Esophagus Test to Improve and Standardize the Clinical Management of Low-Grade Dysplasia in Patients with Barrett’s Esophagus
From Castle Biosciences Inc.
Via Business Wire
Analyst Expectations for Castle Biosciences's Future
Via Benzinga
Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Castle Biosciences Reports Second Quarter 2023 Results
From Castle Biosciences Inc.
Via Business Wire
Castle Biosciences to Present at the Canaccord Genuity 43rd Annual Growth Conference
From Castle Biosciences Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Relmada, DoubleVerify, and Castle and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Castle Biosciences to Release Second Quarter 2023 Financial Results and Host Conference Call on Wednesday, Aug. 2
From Castle Biosciences Inc.
Via Business Wire
Castle Biosciences to Host Second Annual Castle Cares Charity Walk
From Castle Biosciences, Inc.
Via Business Wire
Castle Biosciences Honored as an Arizona Top Workplace for the Second Consecutive Year
From Castle Biosciences Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Castle, Coinbase, Arrival, and BeiGene and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Advance Auto Parts, EPAM, and Castle and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.